Pathophysiology of venous thrombosis

Thrombosis Research

Volumn 123, Issue SUPPL. 4, 2009, Pages

  López, José A ^a   Chen, Junmei ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer associated thrombosis; Deep vein thrombosis (DVT); Microvesicle; Tissue factor; Virchow's triad; von Willebrand factor

Indexed keywords

MUCIN; PADGEM PROTEIN; THROMBOPLASTIN;

ARTICLE; BLOOD VESSEL WALL; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN; NEOPLASM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOGENICITY; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANIMALS; BLOOD COAGULATION; BLOOD VESSELS; HUMANS; NEOPLASMS; REGIONAL BLOOD FLOW; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 62249111330     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70140-9     Document Type: Article

References (47)

1. Chen J., and López J.A. Interactions of platelets with subendothelium and endothelium. Microcirculation 12 (2005) 235-246
2. Tilley R., and Mackman N. Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost 32 (2006) 5-10
3. Friedman M.H., Brinkman A.M., Qin J.J., and Seed W.A. Relation between coronary artery geometry and the distribution of early sudanophilic lesions. Atherosclerosis 98 (1993) 193-199
4. Paterson J.C., and McLachlin J. Precipitating factors in venous thrombosis. Surg Gynecol Obstet 98 (1954) 96-102
5. Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J Clin Pathol 27 (1974) 517-528
6. Andrews R.K., López J.A., and Berndt M.C. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 29 (1997) 91-105
7. Pendu R., Terraube V., Christophe O.D., Gahmberg C.G., de Groot P.G., Lenting P.J., et al. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood 108 (2006) 3746-3752
8. Østerud B., and Björklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 27 (2001) 605-617
9. Gibbs N.M. Venous thrombosis of the lower limbs with particular reference to bed-rest. Br J Surg 45 (1957) 209-236
10. Warlow C., Ogston D., and Douglas A.S. Deep venous thrombosis of the legs after strokes. Part I incidence and predisposing factors. Br Med J 1 (1976) 1178-1181
11. Turpie A.G., Gallus A., Beattie W.S., and Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 27 (1977) 435-438
12. Esmon C.T., Gu J.M., Xu J., Qu D., Stearns-Kurosawa D.J., and Kurosawa S. Regulation and functions of the protein C anticoagulant pathway. Haematologica 84 (1999) 363-368
13. Quinsey N.S., Greedy A.L., Bottomley S.P., Whisstock J.C., and Pike R.N. Antithrombin: in control of coagulation. Int J Biochem Cell Biol 36 (2004) 386-389
14. 2 in venous valve pockets: its possible bearing on thrombogenesis. Br J Surg 68 (1981) 166-170
15. Closse C., Seigneur M., Renard M., Pruvost A., Dumain P., Belloc F., et al. Influence of hypoxia and hypoxia reoxygenation on endothelial P-selectin expression. Thromb Res 85 (1997) 159-164
16. Bernardo A., Ball C., Nolasco L., Choi H., Moake J.L., and Dong J.F. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost 3 (2005) 562-570
17. Wick T.M., Moake J.L., Udden M.M., Eskin S.G., Sears D.A., and McIntire L.V. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 80 (1987) 905-910
18. Arya M., Anvari B., Romo G.M., Cruz M.A., Dong J.F., McIntire L.V., et al. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib IX complex: studies using optical tweezers. Blood 99 (2002) 3971-3977
19. López J.A., and Dong J.F. Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. Semin Hematol 41 (2004) 15-23
20. Koster T., Blann A.D., Briet E., Vandenbroucke J.P., and Rosendaal F.R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
21. Tsai A.W., Cushman M., Rosamond W.D., Heckbert S.R., Tracy R.P., Aleksic N., et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113 (2002) 636-642
22. Ohira T., Cushman M., Tsai M.Y., Zhang Y., Heckbert S.R., Zakai N.A., et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 5 (2007) 1455-1461
23. Larsen T.B., Johnsen S.P., Gislum M., Moller C.A., Larsen H., and Sorensen H.T. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case control study. J Thromb Haemost 3 (2005) 300-304
24. Gill J.C., Endres-Brooks J., Bauer P.J., Marks Jr. W.J., and Montgomery R.R. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69 (1987) 1691-1695
25. Gallinaro L., Cattini M.G., Sztukowska M., Padrini R., Sartorello F., Pontara E., et al. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 111 (2008) 3540-3545
26. Lawson C.A., Yan S.D., Yan S.F., Liao H., Zhou Y.S., Sobel J., et al. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 99 (1997) 1729-1738
27. del Conde I., Shrimpton C.N., Thiagarajan P., and López J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 (2005) 1604-1611
28. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197 (2003) 1585-1598
29. Hrachovinova I., Cambien B., Hafezi-Moghadam A., Kappel-mayer J., Camphausen R.T., Widom A., et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 9 (2003) 1020-1025
30. Tracy P.B., Nesheim M.E., and Mann K.G. Platelet factor Xa receptor. Methods Enzymol 215 (1992) 329-360
31. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96 (2000) 170-175
32. Donati M.B. Cancer and thrombosis. Haemostasis 24 (1994) 128-131
33. Ambrus J.L., Ambrus C.M., Mink I.B., and Pickren J.W. Causes of death in cancer patients. J Med 6 (1975) 61-64
34. Trouseau A. Phlegmasia alba dolens. Lectures on clinical medicine, delivered at the Hotel Dieu, Paris, 3rd edition. Vol. 4. New Sydenham Society (1872) 280-332
35. Dvorak H.F., Van DeWater L., Bitzer A.M., Dvorak A.M., Anderson D., Harvey V.S., et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43 (1983) 4434-4442
36. Dvorak H.F., Quay S.C., Orenstein N.S., Dvorak A.M., Hahn P., Bitzer A.M., et al. Tumor shedding and coagulation. Science 212 (1981) 923-924
37. Carr J.M., Dvorak A.M., and Dvorak H.F. Circulating membrane vesicles in leukemic blood. Cancer Res 45 (1985) 5944-5951
38. Taylor D.D., Lyons K.S., and Gercel-Taylor C. Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol Oncol 84 (2002) 443-448
39. Rao L.V. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 11 (1992) 249-266
40. del Conde I., Bharwani L.D., Dietzen D.J., Pendurthi U., Thiagarajan P., and López J.A. Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 5 (2007) 70-74
41. Tilley R.E., Holscher T., Belani R., Nieva J., and Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 122 (2008) 604-609
42. Davila M., Amirkhosravi A., Coll E., Desai H., Robles L., Colon J., et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6 (2008) 1517-1524
43. Zwicker J.I. Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost 34 (2008) 195-198
44. Lechner D., and Weltermann A. Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?. Semin Thromb Hemost 34 (2008) 199-203
45. Tesselaar M.E., Romijn F.P., Van der Linden I.K., Prins F.A., Bertina R.M., and Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5 (2007) 520-527
46. Khorana A.A., Francis C.W., Menzies K.E., Wang J.G., Hyrien O., Hathcock J., et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6 (2008) 1983-1985
47. Wahrenbrock M., Borsig L., Le D., Varki N., and Varki A. Selectin mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112 (2003) 853-862